Symbol: ARE
CIK: 1035443
Exchange: NYSE
Founded: 1993 (26 years)
HQ: Pasadena, CA, United States
Type of REIT: Equity REIT
Listing Status: Public
Market Capitalization: Large-Cap
REIT Sector: Office
See ARE on Google Finance
See ARE on Yahoo Finance
See ARE on SEC.gov
 |
 |
 |
Click on rating to expand| Rating | Dividend Section | Avg. Rating |
|---|---|---|
| 10 | Dividend Payment Growth: Analysis of how the REIT’s dividend payments have performed during the last three years. | 5.5 |
| 8 | Dividend Payment Consistency: Analysis of how many periods the REIT’s dividends have been paid consistently without a gap in payment. | 4.5 |
| 9 | Dividend to AFFO Payout Ratio Health: Analysis of the REIT’s Dividend to AFFO Payout Ratios during the last four quarters. | 6.9 |
| 6 | Dividend to AFFO Payout Ratio Trend: Analysis of the REIT’s Dividend to AFFO Payout Ratios trend during the last two years. | 5.8 |
| 10 | AFFO Trend: Analysis of the REIT’s AFFO trend during the last two years. | 7.0 |
| 8.6 | Overall Dividend Section Rating: The REIT’s total dividend score from the compilation of the below dividend analysis. | 6.8 |
| Rating | Leverage Section | Avg. Rating |
|---|---|---|
| 10 | Interest Coverage Health: Analysis of the REIT’s Interest Coverage health during the last four quarter. | 6.6 |
| 10 | Interest Coverage Health Trend: Analysis of the REIT’s Interest Coverage health trend during the last two years. | 7.3 |
| 10 | Total Debt Interest Rate Competitiveness: Analysis of the REIT’s Interest Rate to Total Debt competitiveness compared to REIT market. | 8.0 |
| 8 | Total Debt Interest Rate Trend: Analysis of the REIT’s Interest Rate to Total Debt trend during the last two years. | 8.0 |
| 9 | Debt Leverage Health: Analysis of the REIT’s Total Debt to Total Assets. | 6.3 |
| 10 | Debt Leverage Health Trend: Analysis of the REIT’s Total Debt to Total Assets over the last two years. | 7.1 |
| 9.5 | Overall Leverage Section Rating: The REIT’s total Debt Leverage score from the compilation of the above Debt analysis. | 7.5 |
| Rating | Asset & Revenue Section | Avg. Rating |
|---|---|---|
| 8 | G&A Effeciency Level: Analysis of the REIT’s General and Administrative expenses in relationship to its Revenues. | 6.9 |
| 8 | G&A Effeciency Trend: Analysis of the Trend of the REIT’s General and Administrative expenses in relationship to its Revenues. | 7.7 |
| 10 | Revenues Growth: Analysis of how the REIT's Revenue has performed over the last two years. | 6.9 |
| 10 | Total Asset Growth: Analysis of how the REIT has grown its Total Assets over the last two years. | 7.3 |
| 9.0 | Overall Asset & Revenue Section Rating: The REIT’s total Asset, Revenues, and Administrative expenses score from the compilation of the above analysis. | 7.2 |
REITRating is REITNote's Real Estate Investment Trust industry-specific rating and ranking system. The REIT’s score for each analysis is out of ten points, with ten being the best score and zero being the worst. A score of zero can be assigned if the REIT does not meet the criteria for that specific analysis. N/A is assigned if insufficient data is available for a particular analysis. Our REITRating logic is continuously improving, so a REIT’s rating and ranking may change over time. Important Note: REITRating is not a predictor of a REIT’s future performance, it is an evaluation of its past results. Additionally, the REITRating system is for informational purposes only and does not represent financial or investment advice or a recommendation of which REITs to acquire. Learn more.
See complete list of dividend paymemts for ARE
Below are the most recent cash dividends paid by ARE, and the Ex-Dividend Date of the dividend. The percent difference from one dividend payment to the next has also been calculated for your convenience. See complete list of dividend payments for ARE.
| Symbol | Ex Date | Cash Amount | Change in Dividend | Declaration Date | Record Date | Payment Date |
|---|---|---|---|---|---|---|
Login to see Dividend History |
||||||
See Annual Balance Sheet | See Quarterly Balance Sheet
Amounts in USD ($)
| Balance Sheet | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 |
|---|---|---|---|---|
| Total Assets | 15,480,206,000.00 | 14,464,956,000.00 | 14,105,566,000.00 | 13,562,190,000.00 |
| Cash and Equivalents | 315,805,000.00 | 272,130,000.00 | 233,880,000.00 | 321,841,000.00 |
| Investments | 1,291,309,000.00 | 1,129,771,000.00 | 1,155,326,000.00 | 983,725,000.00 |
| Investments Current | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments Non-Current | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Deposit Liabilities | 0.00 | 0.00 | 0.00 | 0.00 |
| Property, Plant & Equipment Net | 12,410,350,000.00 | 11,913,693,000.00 | 11,587,312,000.00 | 11,190,771,000.00 |
| Inventory | 0.00 | 0.00 | 0.00 | 0.00 |
| Tax Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| Trade and Non-Trade Receivables | 9,645,000.00 | 9,798,000.00 | 11,041,000.00 | 8,704,000.00 |
| Trade and Non-Trade Payables | 1,171,377,000.00 | 981,707,000.00 | 907,094,000.00 | 849,274,000.00 |
| Goodwill and Intangible Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 7,125,292,000.00 | 6,570,242,000.00 | 6,692,182,000.00 | 6,562,055,000.00 |
| Shareholders Equity | 7,566,577,000.00 | 7,341,965,000.00 | 6,872,783,000.00 | 6,460,461,000.00 |
| Accumulated Retained Earnings (Deficit) | 0.00 | 0.00 | 0.00 | 0.00 |
| Accumulated Other Comprehensive Income | -10,712,000.00 | -10,435,000.00 | -3,811,000.00 | -2,485,000.00 |
| Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| Assets Non-Current | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Liabilities | 0.00 | 0.00 | 0.00 | 0.00 |
| Liabilities Non-Current | 0.00 | 0.00 | 0.00 | 0.00 |
| Tax Liabilities | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Debt | 5,843,503,000.00 | 5,478,255,000.00 | 5,684,004,000.00 | 5,614,105,000.00 |
| Debt Current | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt Non-Current | 0.00 | 0.00 | 0.00 | 0.00 |
See Annual Income Statement | See Quarterly Income Statement
Amounts in USD ($)
| Income Statement | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 |
|---|---|---|---|---|
| Revenues | 358,842,000.00 | 340,463,000.00 | 341,823,000.00 | 325,034,000.00 |
| Cost of Revenue | 101,501,000.00 | 97,682,000.00 | 99,759,000.00 | 91,908,000.00 |
| Selling, General and Administrative Expense | 24,677,000.00 | 22,385,000.00 | 22,660,000.00 | 22,939,000.00 |
| Research and Development Expense | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 158,764,000.00 | 147,375,000.00 | 142,260,000.00 | 148,102,000.00 |
| Interest Expense | 39,100,000.00 | 40,239,000.00 | 42,244,000.00 | 38,097,000.00 |
| Income Tax Expense | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Consolidated Income | 136,818,000.00 | -18,631,000.00 | 219,359,000.00 | 60,547,000.00 |
| Net Income to Non-Controlling Interests | 7,659,000.00 | 6,053,000.00 | 5,723,000.00 | 5,817,000.00 |
| Net Income | 129,159,000.00 | -24,684,000.00 | 213,636,000.00 | 54,730,000.00 |
| Preferred Dividends Income Statement Impact | 5,561,000.00 | 5,414,000.00 | 4,696,000.00 | 2,714,000.00 |
| Net Income Common Stock | 123,598,000.00 | -30,098,000.00 | 208,940,000.00 | 52,016,000.00 |
| Earnings per Basic Share | 1.11 | -0.33 | 2.01 | 0.51 |
| Earnings per Diluted Share | 1.11 | -0.33 | 1.99 | 0.51 |
| Weighted Average Shares | 112,728,422.00 | 107,526,601.00 | 105,757,371.00 | 102,982,599.00 |
| Weighted Average Shares Diluted | 0.00 | 0.00 | 0.00 | 0.00 |
See Annual Cash Flow | See Quarterly Cash Flow
Amounts in USD ($)
| Cash Flow | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 |
|---|---|---|---|---|
| Capital Expenditure | -241,049,000.00 | -263,480,000.00 | -232,463,000.00 | -224,821,000.00 |
| Net Cash Flow - Business Acquisitions and Disposals | -52,634,000.00 | -38,507,000.00 | 35,577,000.00 | -22,161,000.00 |
| Net Cash Flow - Investment Acquisitions and Disposals | -22,292,000.00 | -15,399,000.00 | -42,797,000.00 | -51,623,000.00 |
| Net Cash Flow from Financing | 640,806,000.00 | 280,627,000.00 | 251,320,000.00 | 605,167,000.00 |
| Issuance (Repayment) of Debt Securities | 344,866,000.00 | -206,733,000.00 | 69,747,000.00 | 410,250,000.00 |
| Issuance (Purchase) of Equity Shares | 0.00 | 596,769,000.00 | 296,325,000.00 | 300,838,000.00 |
| Payment of Dividends & Other Cash Distributions | -109,342,000.00 | -100,000,000.00 | -97,592,000.00 | -91,980,000.00 |
| Net Cash Flow from Investing | -734,333,000.00 | -397,611,000.00 | -495,250,000.00 | -670,861,000.00 |
| Net Cash Flow from Operations | 136,730,000.00 | 156,251,000.00 | 155,847,000.00 | 129,320,000.00 |
| Effect of Exchange Rate Changes on Cash | 472,000.00 | -1,017,000.00 | 122,000.00 | -767,000.00 |
| Net Cash Flow / Change in Cash & Cash Equivalents | 43,675,000.00 | 38,250,000.00 | -87,961,000.00 | 62,859,000.00 |
| Share Based Compensation | 11,029,000.00 | 9,810,000.00 | 9,986,000.00 | 7,975,000.00 |
| Depreciation, Amortization & Accretion | 134,087,000.00 | 124,990,000.00 | 119,600,000.00 | 118,852,000.00 |
Alexandria Real Estate Equities, Inc. (NYSE:ARE), an S&P 500® company, is an urban office REIT uniquely focused on collaborative life science and technology campuses in AAA innovation cluster locations, with a total market capitalization of $18.8 billion and an asset base in North America of 32.0 million SF as of June 30, 2018. The asset base in North America includes 21.5 million RSF of operating properties and 3.5 million RSF of development and redevelopment of new Class A properties currently undergoing construction and pre-construction activities with target delivery dates ranging from 2018 through 2020. Additionally, the asset base in North America includes 7.0 million SF of intermediate-term and future development projects. Founded in 1994, Alexandria pioneered this niche and has since established a significant market presence in key locations, including Greater Boston, San Francisco, New York City, San Diego, Seattle, Maryland, and Research Triangle Park. Alexandria has a longstanding and proven track record of developing Class A properties clustered in urban life science and technology campuses that provide its innovative tenants with highly dynamic and collaborative environments that enhance their ability to successfully recruit and retain world-class talent and inspire productivity, efficiency, creativity, and success. Alexandria also provides strategic capital to transformative life science and technology companies through its venture capital arm. We believe our unique business model and diligent underwriting ensure a high-quality and diverse tenant base that results in higher occupancy levels, longer lease terms, higher rental income, higher returns, and greater long-term asset value.
| REIT | Exchange | Market Capitalization | Sector | Country |
|---|---|---|---|---|
| Retail Opportunity Investments Corp. (ROIC) | NASDAQ | Mid-Cap | Retail | United States |
| Vornado Realty Trust (VNO) | NYSE | Large-Cap | Diversified Residential Office | United States |
| Chesapeake Lodging Trust (CHSP) | NYSE | Small-Cap | Hotel | United States |
| Physicians Realty Trust (DOC) | NYSE | Mid-Cap | Health Care | United States |
